The Leadership Team at Intercept Pharmaceuticals is responsible for steering the strategic direction of the company, overseeing the development of innovative treatments for chronic liver diseases. This team collaborates across regulatory affairs, clinical research, market access, and operational excellence to ensure that the organization's objectives align with its mission to advance novel therapeutics and enhance patient care. Together, they foster a culture of innovation and compliance while managing risks and driving sustainable growth.
Keith White
Vice President Market Access
Linda Richardson
CCO
M. Michelle Berrey
President, Research & Developm...
Meghan Altman Stoll
Senior Vice President, Head Of...
Molly Walker
Vice President Regulatory Affa...
Paul Nitschmann
SVP Regulatory Affairs
Richard Johnson
Senior Vice President Head Of ...
Rocco Venezia
CAO
Valerie Keller
Executive Administrator To Chi...
Victoria Carey
Senior Vice President, US Comm...
View all